Genetic variation in Interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin

Genetic variation in Interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin

Background and aims. Genetic variations in the interleukin 28B (IL28B) gene have been associated with viral response to PEG-interferon-a/ribavirin (PR) therapy in hepatitis C virus (HCV) genotype 1 infected patients from North America, Europe and Asia. The importance of these IL28B variants for Arge...

Full description

Bibliographic Details
Main Authors: Ezequiel Ridruejo, Ángela Solano, Sebastián Marciano, Omar Galdame, Raúl Adrover, Daniel Cocozzella, Dreanina Delettieres, Alfredo Martínez, Adrián Gadano, Oscar G. Mandό, Marcelo O. Silva
Format: Article
Language:English
Published: Elsevier 2011-10-01
Series:Annals of Hepatology
Subjects:
Hepatitis C
Sustained virological response
IL28B
Single-nucleotide polymorphisms
European ancestry
Latin American patients
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119315121

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119315121

Similar Items